These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8549078)

  • 1. Septic patients in multiple organ failure can oxidize infused glucose, but non-oxidative disposal (storage) is impaired.
    Green CJ; Campbell IT; O'Sullivan E; Underhill S; McLaren DP; Hipkin LJ; MacDonald IA; Russell J
    Clin Sci (Lond); 1995 Dec; 89(6):601-9. PubMed ID: 8549078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of substrate utilization with somatostatin in patients with secondary multiple organ dysfunction syndrome.
    Arnold J; Campbell IT; Hipkin LJ; Keegan M; Jenkins S; O'Sullivan E; Chadwick S
    Crit Care Med; 1995 Jan; 23(1):71-7. PubMed ID: 8001390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective impairment of glucose storage in human sepsis.
    Saeed M; Carlson GL; Little RA; Irving MH
    Br J Surg; 1999 Jun; 86(6):813-21. PubMed ID: 10383584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
    Yokoyama H; Emoto M; Mori K; Araki T; Teramura M; Koyama H; Shoji T; Inaba M; Nishizawa Y
    J Clin Endocrinol Metab; 2006 Jan; 91(1):290-4. PubMed ID: 16234307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of insulin on glucose metabolism and energy expenditure in septic patients.
    Rusavy Z; Sramek V; Lacigova S; Novak I; Tesinsky P; Macdonald IA
    Crit Care; 2004 Aug; 8(4):R213-20. PubMed ID: 15312220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemia influences on glucose metabolism in sepsis during hyperinsulinemic clamp.
    Rusavy Z; Macdonald IA; Sramek V; Lacigova S; Tesinsky P; Novak I
    JPEN J Parenter Enteral Nutr; 2005; 29(3):171-5. PubMed ID: 15837776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fasting on fatty acid kinetics and on the cardiovascular, thermogenic and metabolic responses to the glucose clamp.
    Webber J; Taylor J; Greathead H; Dawson J; Buttery PJ; Macdonald IA
    Clin Sci (Lond); 1994 Dec; 87(6):697-706. PubMed ID: 7874862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure.
    Arnold J; Campbell IT; Samuels TA; Devlin JC; Green CJ; Hipkin LJ; MacDonald IA; Scrimgeour CM; Smith K; Rennie MJ
    Clin Sci (Lond); 1993 Jun; 84(6):655-61. PubMed ID: 8334812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.
    Surmely JF; Guenat E; Philippe J; Dussoix P; Schneiter P; Temler E; Vaxillaire M; Froguel P; Jéquier E; Tappy L
    Diabetes; 1998 Sep; 47(9):1459-63. PubMed ID: 9726235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intravenous lipids in critically ill patients with sepsis without and with hepatic failure.
    Druml W; Fischer M; Ratheiser K
    JPEN J Parenter Enteral Nutr; 1998; 22(4):217-23. PubMed ID: 9661122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
    Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
    Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man.
    Del Prato S; Leonetti F; Simonson DC; Sheehan P; Matsuda M; DeFronzo RA
    Diabetologia; 1994 Oct; 37(10):1025-35. PubMed ID: 7851681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired nonoxidative glucose metabolism in patients with liver cirrhosis: effects of two insulin doses.
    Riggio O; Merli M; Leonetti F; Giovannetti P; Foniciello M; Folino S; Tamburrano G; Capocaccia L
    Metabolism; 1997 Jul; 46(7):840-3. PubMed ID: 9225841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise.
    Yokoyama H; Mori K; Emoto M; Araki T; Teramura M; Mochizuki K; Tashiro T; Motozuka K; Inoue Y; Nishizawa Y
    Diabetes Obes Metab; 2008 May; 10(5):400-7. PubMed ID: 18410564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
    Widén EI; Eriksson JG; Groop LC
    Diabetes; 1992 Mar; 41(3):354-8. PubMed ID: 1551495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between insulin-mediated glucose disposal and lipid metabolism in man.
    Lillioja S; Bogardus C; Mott DM; Kennedy AL; Knowler WC; Howard BV
    J Clin Invest; 1985 Apr; 75(4):1106-15. PubMed ID: 3886702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
    Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
    Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.